Michael M Hammond1, Changyu Shen2,3,4, Stephanie Li4,5, Dhruv S Kazi2,3,4, Marwa A Sabe3,4, A Reshad Garan3,4, Lawrence J Markson4,6, Warren J Manning3,4,7, Allan L Klein8, Sherif F Nagueh9, Jordan B Strom2,3,4. 1. Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States of America. 2. Division of Cardiovascular Medicine, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, United States of America. 3. Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States of America. 4. Harvard Medical School, Boston, MA, United States of America. 5. Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, United States of America. 6. Information Systems, Beth Israel Deaconess Medical Center, Boston, MA, United States of America. 7. Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, United States of America. 8. The Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States of America. 9. Department of Cardiology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX, United States of America.
Abstract
BACKGROUND: Limited data exist on the differential ability of variables on transthoracic echocardiogram (TTE) to predict heart failure (HF) readmission across the spectrum of left ventricular (LV) systolic function. METHODS: We linked 15 years of TTE report data (1/6/2003-5/3/2018) at Beth Israel Deaconess Medical Center to complete Medicare claims. In those with recent HF, we evaluated the relationship between variables on baseline TTE and HF readmission, stratified by LVEF. RESULTS: After excluding TTEs with uninterpretable diastology, 5,900 individuals (mean age: 76.9 years; 49.1% female) were included, of which 2545 individuals (41.6%) were admitted for HF. Diastolic variables augmented prediction compared to demographics, comorbidities, and echocardiographic structural variables (p < 0.001), though discrimination was modest (c-statistic = 0.63). LV dimensions and eccentric hypertrophy predicted HF in HF with reduced (HFrEF) but not preserved (HFpEF) systolic function, whereas LV wall thickness, NT-proBNP, pulmonary vein D- and Ar-wave velocities, and atrial dimensions predicted HF in HFpEF but not HFrEF (all interaction p < 0.10). Prediction of HF readmission was not different in HFpEF and HFrEF (p = 0.93). CONCLUSIONS: In this single-center echocardiographic study linked to Medicare claims, left ventricular dimensions and eccentric hypertrophy predicted HF readmission in HFrEF but not HFpEF and left ventricular wall thickness predicted HF readmission in HFpEF but not HFrEF. Regardless of LVEF, diastolic variables augmented prediction of HF readmission compared to echocardiographic structural variables, demographics, and comorbidities alone. The additional role of medication adherence, readmission history, and functional status in differential prediction of HF readmission by LVEF category should be considered for future study.
BACKGROUND: Limited data exist on the differential ability of variables on transthoracic echocardiogram (TTE) to predict heart failure (HF) readmission across the spectrum of left ventricular (LV) systolic function. METHODS: We linked 15 years of TTE report data (1/6/2003-5/3/2018) at Beth Israel Deaconess Medical Center to complete Medicare claims. In those with recent HF, we evaluated the relationship between variables on baseline TTE and HF readmission, stratified by LVEF. RESULTS: After excluding TTEs with uninterpretable diastology, 5,900 individuals (mean age: 76.9 years; 49.1% female) were included, of which 2545 individuals (41.6%) were admitted for HF. Diastolic variables augmented prediction compared to demographics, comorbidities, and echocardiographic structural variables (p < 0.001), though discrimination was modest (c-statistic = 0.63). LV dimensions and eccentric hypertrophy predicted HF in HF with reduced (HFrEF) but not preserved (HFpEF) systolic function, whereas LV wall thickness, NT-proBNP, pulmonary vein D- and Ar-wave velocities, and atrial dimensions predicted HF in HFpEF but not HFrEF (all interaction p < 0.10). Prediction of HF readmission was not different in HFpEF and HFrEF (p = 0.93). CONCLUSIONS: In this single-center echocardiographic study linked to Medicare claims, left ventricular dimensions and eccentric hypertrophy predicted HF readmission in HFrEF but not HFpEF and left ventricular wall thickness predicted HF readmission in HFpEF but not HFrEF. Regardless of LVEF, diastolic variables augmented prediction of HF readmission compared to echocardiographic structural variables, demographics, and comorbidities alone. The additional role of medication adherence, readmission history, and functional status in differential prediction of HF readmission by LVEF category should be considered for future study.
Authors: Hsin-Yueh Liang; Sanderson A Cauduro; Patricia A Pellikka; Kent R Bailey; Brandon R Grossardt; Eric H Yang; Chiranjit Rihal; James B Seward; Fletcher A Miller; Theodore P Abraham Journal: Am J Cardiol Date: 2006-01-30 Impact factor: 2.778
Authors: Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner Journal: J Am Soc Echocardiogr Date: 2016-04 Impact factor: 5.251
Authors: Giovanni Benfari; Wayne L Miller; Clémence Antoine; Andrea Rossi; Grace Lin; Jae K Oh; Veronique L Roger; Prabin Thapa; Maurice Enriquez-Sarano Journal: JACC Heart Fail Date: 2019-08-07 Impact factor: 12.035
Authors: Amil M Shah; Maja Cikes; Narayana Prasad; Guichu Li; Stoyan Getchevski; Brian Claggett; Adel Rizkala; Ilya Lukashevich; Eileen O'Meara; John J Ryan; Sanjiv J Shah; Wilfred Mullens; Michael R Zile; Carolyn S P Lam; John J V McMurray; Scott D Solomon Journal: J Am Coll Cardiol Date: 2019-12-10 Impact factor: 24.094
Authors: Sherif F Nagueh; Rajat Bhatt; Rey P Vivo; Selim R Krim; Sebastian Imre Sarvari; Kristoffer Russell; Thor Edvardsen; Otto A Smiseth; Jerry D Estep Journal: Circ Cardiovasc Imaging Date: 2011-03-11 Impact factor: 7.792
Authors: Harun Kundi; Linda R Valsdottir; Jeffrey J Popma; David J Cohen; Jordan B Strom; Duane S Pinto; Changyu Shen; Robert W Yeh Journal: Circ Cardiovasc Qual Outcomes Date: 2018-10
Authors: Paul A Heidenreich; Nancy M Albert; Larry A Allen; David A Bluemke; Javed Butler; Gregg C Fonarow; John S Ikonomidis; Olga Khavjou; Marvin A Konstam; Thomas M Maddox; Graham Nichol; Michael Pham; Ileana L Piña; Justin G Trogdon Journal: Circ Heart Fail Date: 2013-04-24 Impact factor: 8.790
Authors: Jan F Nauta; Yoran M Hummel; Jasper Tromp; Wouter Ouwerkerk; Peter van der Meer; Xuanyi Jin; Carolyn S P Lam; Jeroen J Bax; Marco Metra; Nilesh J Samani; Piotr Ponikowski; Kenneth Dickstein; Stefan D Anker; Chim C Lang; Leong L Ng; Faiez Zannad; Gerasimos S Filippatos; Dirk J van Veldhuisen; Joost P van Melle; Adriaan A Voors Journal: Eur J Heart Fail Date: 2019-11-11 Impact factor: 15.534